Home / Workshop Program

Workshop Program

The event will operate on Queensland time / AEST / UTC+10h / GMT+10h
The workshop will be held on level 3 at Twin Towns Resort in River Room. Please see the Level 3 Events Plan.
Also have a look at Twin Towns Delegate Map for access details to Twin Towns Resort

 

27th of April 2018

TimeTitle & SpeakerDuration
11:30Registration
 
 
12:00 – 12:15Welcome and Introduction
 
15min
12:15 – 12:45The International Quality Network for Pathology (IQN-Path) update
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
12:50 – 13:20A National Population-based Approach to Laboratory Quality Improvement
Niall Swan, St Vincent’s University Hospital and UCD School of Medicine, Dublin, Ireland
30min
13:25 – 13:55RCPAQAP Update and the Challenges of implementing PD-L1 EQA
Julia Pagliuso, RCPAQAP, St Leonards NSW, Australia
30min
14:00 – 14:30Review of results of ALK EQA over 2 years
Zenobia Haffajee, RCPAQAP, St Leonards NSW, Australia
30min
14:30 – 15:00Coffee Break
 
30min
15:00 – 15:30TMA based external quality assurance, the cIQc programme.
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
15:35 – 16:05Biobanking and quality assurance management relevant to IHC: a North American perspective
Christopher Andry, Boston University Medical Center, Boston, USA
30min
16:10 – 16:40Digital Immunohistochemistry and Personalized Medicine in Norway.
Emiel Janssen, Stavanger University Hospital, Norway
30min
16:45 – 17:15An update on Australian medical laboratory accreditation requirements.
Gillian Treloar, NATA (National Association of Testing Authorities, Australia), Melbourne, Australia
30min
18:30 – 20:30Cocktail Party – sponsored by Metagene
 
2hrs
 

28th of April 2018

TimeTitle & SpeakerDuration
8:00Registration
 
 
8:30 – 9:10A Window Onto the Molecular Biology of Tumors
Allen Gown, PhenoPath and Fred Hutchinson Cancer Research Center, Seattle, USA: Next Generation Immunohistochemistry
40min
9:15 – 9:45The role of p16 immunohistochemistry in head and neck tumor diagnosis and management
Jane Dahlstrom, ACT Pathology, Canberra University Hospital and Australian National University Medical School, Australia
30min
9:50 – 10:20Doing it right – Mismatch repair (MMR) for determining eligibility for immuno-modulator therapy
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
10:25 – 11:00Coffee Break
 
35min
11:00 – 11:30Standardization and optimization of antibodies in gastrointestinal cancer diagnosis
Nathan Acott, PathWest Laboratory Medicine, Nedlands WA, Australia
30min
11:35 – 12:05Standardization and optimization of B-Raf v600e
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
12:10 – 12:40Tests Predictive of Response to PD-L1 and PD-1 Targeted Therapies
Allen Gown PhenoPath and Fred Hutchinson Cancer Research Center, Seattle, USA
30min
12:45 – 13:30Lunch
 
45min
13:30 – 14:00From the Newfoundland scandal to present day – Optimization of breast biomarker testing in Canada
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
14:05 – 14:35The role of IHC in breast cancer diagnosis and optimization of patient management
Emiel Janssen, Stavanger University Hospital, Norway:
30min
14:40 – 15:10Standardization and optimization of antibodies in breast cancer diagnosis
Nathan Acott, PathWest Laboratory Medicine, Nedlands WA, Australia
30min
15:10 – 15:40Coffee Break
 
30min
15:45 – 16:15Immunohistochemistry in Endocrine Tumours, a Diagnostic and Theranostic Role
Niall Swan, St Vincent’s Univesity Hospital and UCD School of Medicine, Dublin, Ireland
30min
16:20 – 16:50Standardization and optimization in lung cancer diagnosis
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
16:55 – 17:25Standardization and optimization of antibodies in lung cancer diagnosis
Nathan Acott, PathWest Laboratory Medicine, Nedlands WA, Australia
30min
19:30 –Drinks and Gala Dinner
 
 

29th of April 2018

TimeTitle & SpeakerDuration
8:00Registration
 
 
8:30 – 9:00The role of Immunohistochemistry in the diagnosis and management of unknown soft tissue tumours.
John Slavin, St Vincent’s Univesity Hospital, VIC Melbourne, Australia
30min
9:05 – 9:35Rationale and Cost-Effective Use of Antibody Panels in Immunohistochemistry: Allen Gown, PhenoPath Seattle
Allen Gown, PhenoPath and Fred Hutchinson Cancer Research Center, Seattle, USA
30min
9:40 – 10:10Digital and quantitative immunohistochemistry in Bladder cancer
Emiel Janssen, Stavanger University Hospital, Norway
30min
10:15 – 10:45Coffee Break
 
30min
10:50 – 11:20Specimen quality and pre-analytic variables
Christopher Andry, Boston University Medical Center, Boston, USA
30min
11:25 – 11:55The crispy brown stain in IHC – can it be misleading; Errors made and lessons learnt
Beena Kumar, Monash Medical Centre, Melbourne, VIC, Australia
30min
12:00 – 12:30Introducing iCAPCs (Immunohistochemistry Critical Assay Performance Controls )
John Garratt, Canadian Immunohistochemistry Quality Control (cIQc), Vancouver Canada
30min
12:35 – 13:05Immunohistochemistry- Headaches Heartbreaks and Heroics
David Gan, QML Pathology Brisbane and RCPASQAP St Leonards NSW, Australia
30min